van Gemst, Jasper J. and Passmann, Nathalie J. H. G. and Rops, Angelique L. W. M. M. and van Kuppevelt, Toin H. and Berden, Jo H. and Loeven, Markus A. and Rabelink, Ton J. and Smeets, Bart and van der Vlag, Johan and Karamanos, Nikos K. (2021) Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis. PLOS ONE, 16 (12). e0261722. ISSN 1932-6203
![[thumbnail of journal.pone.0261722.pdf]](http://geographical.go2journals.com/style/images/fileicons/text.png)
journal.pone.0261722.pdf - Published Version
Download (1MB)
Abstract
Glomerulonephritis is an acquired serious glomerular disease, which involves the interplay of many factors such as cytokines, chemokines, inflammatory cells, and heparan sulfate (HS). We previously showed that blocking of inflammatory heparan sulfate domains on cultured glomerular endothelium by specific anti-HS single chain antibodies reduced polymorphonuclear cell (PMN) adhesion and chemokine binding. We hypothesized that injection of anti-HS antibodies in PMN-driven experimental glomerulonephritis should reduce glomerular influx of PMNs and thereby lead to a better renal outcome. In contrast to our hypothesis, co-injection of anti-HS antibodies did not alter the final outcome of anti-glomerular basement membrane (anti-GBM)-induced glomerulonephritis. Glomerular PMN influx, normally peaking 2 hours after induction of glomerulonephritis with anti-GBM IgG was not reduced by co-injection of anti-HS antibodies. Four days after induction of glomerulonephritis, albuminuria, renal function, glomerular hyalinosis and fibrin deposition were similar in mice treated and not treated with anti-HS antibodies. Interestingly, we observed transient effects in mice co-injected with anti-HS antibodies compared to mice that did not receive anti-HS antibodies: (i) a decreased renal function 2 hours and 1 day after induction of glomerulonephritis; (ii) an increased albuminuria after 2 hours and 1 day; (iii) an increased glomerular fibrin deposition after 1 day; (iv) a reduced glomerular macrophage influx after 1 day; (v) a sustained glomerular presence of PMNs at day 1 and 4, accompanied by an increased renal expression of IL-6, CXCL1, ICAM-1, L-selectin, CD11b and NF-κB. The mechanism underlying these observations induced by anti-HS antibodies remains unclear, but may be explained by a temporarily altered glycocalyx and/or altered function of PMNs due to the binding of anti-HS antibodies. Nevertheless, the evaluated anti-HS antibodies do not show therapeutic potential in anti-GBM-induced glomerulonephritis. Future research should evaluate other strategies to target HS domains involved in inflammatory processes during glomerulonephritis.
Item Type: | Article |
---|---|
Subjects: | Opene Prints > Biological Science |
Depositing User: | Managing Editor |
Date Deposited: | 28 Nov 2022 06:52 |
Last Modified: | 10 Jul 2024 14:01 |
URI: | http://geographical.go2journals.com/id/eprint/370 |